Oncology: Tollys earns ‘Best-in-class therapeutic innovation’ award from MATWIN for its drug candidate TL-532
AELIX Therapeutics appoints Dr Melanie Rolli as CEO
MATWIN highlights four innovative projects in the fight against cancer
Clean Biologics SAS acquires Biodextris Inc.
Exelixis Expands its Biotherapeutics Portfolio with Acquisition of GamaMabs Pharma’s First-in-Class Humanized Antibody Program Against a Novel Oncology Target
Tollys appoints Amina Zinaï, MD, as head of clinical development
Calixar invests €1 Million in pipeline of highly druggable membrane protein targets and native antigens
Domain Therapeutics presents most recent developments of its BRET technology portfolio at AACR and ASPET events
